Garwood Medical Devices: Using electrical stimulation to reduce joint replacement infections
Garwood Medical Devices is betting that electrical stimulation technology it has licensed from the University at Buffalo could make joint replacement infections less common. A University of Buffalo news release in March said Garwood had engaged in another round of animal testing of its Biofilm Disruption Device. Company officials plan to submit an application next year to U.S. FDA for de novo classification.
The company raised nearly $1.7 million earlier this year, according to an SEC Form D filed in March.